CIDRAP newsletters options
A study published in Vaccine shows that even small doses of the yellow fever vaccine are likely to offer protection against the virus for up to 8 years after vaccination. The information reassures countries like Brazil, who have used fractional dosing in an effort to stretch supplies of the vaccine during recent outbreaks.
The detailed look at prescribing at a VA hospital, which was high, hints that national estimates may be too low.
Kenya has reported 36 more illnesses in its Rift Valley fever outbreak, lifting the total to 90, the World Health Organization (WHO) African regional office said in its latest weekly health emergencies update. No new deaths have been reported, keeping the fatality count at 10.
A new European surveillance report shows rising resistance to key antibiotics, and increasing trends in multidrug resistance, in invasive gram-negative bacteria.
Findings hint that pregnancy losses from Zika may be underestimated and that damage can take place, even without symptoms.
The Indiana State Department of Health (ISDH) announced the first case of variant influenza H3N2 (H3N2v) detected this year in a county fairgoer who was in close proximity to pigs. The Centers for Disease control and Prevention (CDC) confirmed the infection on Jun 29.
A new study by researchers with the University of Chicago Medical Center has found that use of a clinical decision support system at the hospital significantly increased the number of antimicrobial reviews and interventions while maintaining a sustained impact on antimicrobial utilization.
A list of critical-need antimicrobials would guide awards, which include incentives and responsibilities for companies, including stewardship reporting.
Two countries reported circulating vaccine-derived polio cases this week, according to the latest update from the Global Polio Eradication Initiative (GPEI). In addition to new cases from the Democratic Republic of the Congo (DRC) and Somalia, the GPEI confirmed an outbreak of circulating vaccine derived polio in Papua New Guinea.
The US Food and Drug Administration (FDA) yesterday released guidance to help animal-drug makers meet requirements for reporting antimicrobial sales. The step follows the 2016 implementation of a final rule that revised annual reporting requirements for companies that sell or distribute antibiotics for use in food-producing animals.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Patients incorrectly labeled as allergic to penicillin are more likely to receive broad-spectrum antibiotics, a practice that promotes resistance.
Lessons learned from 140 outbreaks involving nearly 5,000 people and steps to minimize the risk of getting sick from swimming.
The Democratic Republic of the Congo's (DRC's) health ministry said today that all contacts of the last confirmed case have completed their 21-day monitoring periods with none showing any signs of illness, marking the beginning of the countdown to the end of the nation's ninth Ebola outbreak.
A financial incentive program for United Kingdom National Health Service (NHS) local groups reduced antibiotic prescribing by general practitioners for common respiratory infections by 3%, a research team based at Imperial College London reported today in the Journal of Antimicrobial Chemotherapy.
Men had higher expression of antimicrobial resistance genes, a finding that may have implications for the growing threat of resistant gonorrhea.
The US Food and Drug Administration (FDA) has granted fast-track approval for a new oral antiviral with a different mechanism of action than neuraminidase inhibitors that offers one-dose treatment, according to a Jun 25 statement from Genentech, part of the Roche Group. The drug, called baloxavir marboxil, was approved in Japan in February for the treatment of influenza A and B in adult and pediatric patients.
Intensive surveillance activities in the Democratic Republic of Congo's Ebola virus outbreak have turned up three more suspected cases in the remote town of Bikoro, according to an update today from the country's health ministry.
In a separate report, researchers from Liberia weigh in on urban spread in the DRC and recommend strategies for reducing that type of Ebola transmission.
Only 16 antibiotic candidates against high-priority pathogens are in progress.
